Classification of diseases and disorders is achieved through international clinical and scientific consensus.<\/p>
<\/p>
The current version of the World Health Organization\u2019s International Classification of Diseases (ICD10) includes fibromyalgia under \u2018Diseases of the musculoskeletal system and connective tissue\u2019 in the category \u2018Other soft tissue disorders, not elsewhere classified\u2019. ICD-11, which will be presented at the World Health Assembly in May 2019 for adoption by member states, includes fibromyalgia under \u2018General symptoms, signs or clinical findings\u2019 in the category of \u2018chronic widespread pain\u2019.<\/p>
<\/p>
The Department\u2019s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including fibromyalgia. It is not usual practice to ring-fence funds for particular topics or conditions; applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. NIHR support for fibromyalgia research over the last five years includes £1.8 million funding for research projects and £0.6 million funding for clinical trials through the NIHR Clinical Research Network. The NIHR has also managed infrastructure supporting fibromyalgia research. Information on individual projects funded by the NIHR can be found at the following link:<\/p>
<\/p>